Publications - Page 37 sur 57 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Maladies pulmonaires chroniques liées à l’environnement
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy.

Vitte J, Michel M, Malinovschi A, Caminati M, Odebode A, Annesi-Maesano I, Caimmi DP, Cassagne C, Demoly P, Heffler E, Menu E, Nwaru BI, Sereme Y, Ranque S, Raulf M, Feleszko W, Janson C, Galán C; EAACI Task Force on Allergic Bronchopulmonary Aspergillosis.

Allergy. 2022 Nov;77(11):3199-3216.
Hypertension pulmonaire (HTP)
Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα.

García Aguilar H, Gorenflo M, Ivy DD, Moledina S, Castaldi B, Ishida H, Cześniewicz P, Kusa J, Miera O, Pattathu J, Weng KP, Ablonczy L, Apitz C, Katona M, Kurosaki K, Pulido T, Yamagishi H, Yasuda K, Cisternas G, Goth M, Lippert S, Radomskyj A, Saleh S, Willmann S, Wirsching G, Bonnet D, Beghetti M.

Pulm Circ. 2022 Jul 1;12(3):e12133.
Hypertension pulmonaire (HTP)
Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα.

Cai Z, Tian S, Klein T, Tu L, Geenen LW, Koudstaal T, van den Bosch AE, de Rijke YB, Reiss IKM, Boersma E, van der Ley C, Van Faassen M, Kema I, Duncker DJ, Boomars KA, Tran-Lundmark K, Guignabert C, Merkus D.

Sci Rep. 2022 Jul 19;12(1):12326.
Hypertension pulmonaire (HTP)
Smooth muscle Rac1 contributes to pulmonary hypertension.

Dilasser F, Rio M, Rose L, Tesse A, Guignabert C, Loirand G, Sauzeau V.

Br J Pharmacol. 2022 Jul;179(13):3418-3429.
Hypertension pulmonaire (HTP)
Severe pulmonary hypertension associated with COPD: long-term results of a prospective French multicentre cohort.

Dauriat G, Reynaud-Gaubert M, Cottin V, Lamia B, Montani D, Belhadi D, Humbert M, Laouenan C, Mal H; French group of investigators on severe PH-COPD.

Eur Respir J. 2022 Jul 7;60(1):2102897.
Hypertension pulmonaire (HTP)
Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease.

Fournier E, Selegny M, Amsallem M, Haddad F, Cohen S, Valdeolmillos E, Le Pavec J, Humbert M, Isorni MA, Azarine A, Sitbon O, Jais X, Savale L, Montani D, Fadel E, Zoghbi J, Belli E, Hascoët S.

Rev Esp Cardiol (Engl Ed). 2022 Aug 6:S1885-5857(22)00209-2.
Hypertension pulmonaire (HTP)
Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.

Le Vely B, Phan C, Berrebeh N, Thuillet R, Ottaviani M, Chelgham MK, Chaumais MC, Amazit L, Humbert M, Huertas A, Guignabert C, Tu L.

Am J Respir Cell Mol Biol. 2022 Aug;67(2):215-226.
Hypertension pulmonaire (HTP)
Screening for pulmonary veno-occlusive disease in heterozygous EIF2AK4 variant carriers.

Lechartier B, Girerd B, Eyries M, Beurnier A, Humbert M, Montani D.

Eur Respir J. 2022 Aug 18;60(2):2200760.
Hypertension pulmonaire (HTP)
Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE).

Howard LS, Rosenkranz S, Frantz RP, Hemnes AR, Pfister T, Hsu Schmitz SF, Skåra H, Humbert M, Preston IR.

Chest. 2022 Sep 8:S0012-3692(22)03707-2.
Hypertension pulmonaire (HTP)
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.

Vicaire H, Pavec JL, Mercier O, Montani D, Boucly A, Roche A, Pradère P, Dauriat G, Feuillet S, Pichon J, Jevnikar M, Beurnier A, Jaïs X, Fadel E, Sitbon O, Humbert M, Savale L.

J Heart Lung Transplant. 2022 Sep;41(9):1285-1293.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy.

Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα.

Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Rα.

Smooth muscle Rac1 contributes to pulmonary hypertension.

Severe pulmonary hypertension associated with COPD: long-term results of a prospective French multicentre cohort.

Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease.

Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.

Screening for pulmonary veno-occlusive disease in heterozygous EIF2AK4 variant carriers.

Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE).

Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.